Patents by Inventor Rohit K. Jangra

Rohit K. Jangra has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • INFECTIOUS RECOMBINANT VESICULAR STOMATITIS VIRUS (RVSV) BEARING THE SPIKE GLYCOPROTEIN S OF SARS-COV-2 AND USES THEREOF
    Publication number: 20240229066
    Abstract: Provided herein are recombinant vesicular stomatitis virus (rVSV) or rVSV vector comprising nucleic acid encoding the spike glycoprotein S of SARS-COV-2, compositions comprising such vectors or viruses, as well as screening methods, diagnostic methods, prophylactic and therapeutic methods using such vectors or viruses.
    Type: Application
    Filed: January 6, 2023
    Publication date: July 11, 2024
    Inventors: Kartik Chandran, Rohit K. Jangra, Maria Dieterle, Denise Haslwanter
  • Methods and assays for treating hantavirus infections
    Patent number: 10105433
    Abstract: Methods and assays are disclosed for treating a subject with a hantavirus infection using an agent that binds to protocadherin-1 (PCDH1) or inhibits expression of protocadherin-1 (PCDH1).
    Type: Grant
    Filed: February 25, 2015
    Date of Patent: October 23, 2018
    Assignee: Albert Einstein College of Medicine, Inc.
    Inventors: Kartik Chandran, Thijin R. Brummelkamp, Lucas T. Jae, Rohit K. Jangra
  • METHODS AND ASSAYS FOR TREATING HANTAVIRUS INFECTIONS
    Publication number: 20170173141
    Abstract: Methods and assays are disclosed for treating a subject with a hantavirus infection using an agent that binds to proto cadhenn-1 (PCDH1) or inhibits expression of protocadherin-1 (PCDH1).
    Type: Application
    Filed: February 25, 2015
    Publication date: June 22, 2017
    Applicant: ALBERT EINSTEIN COLLEGE OF MEDICINE, INC.
    Inventors: Kartik Chandran, Thijin R. Brummelkamp, Lucas T. Jae, Rohit K. Jangra